Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.61K | Sales 2023 | 555 366.87 | Capitalization | 39.72M 26.25M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.86M | Net income 2023 | -20M -13.22M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.87M | Net cash position 2023 | 3.44M 2.28M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |